MicroRNA-140 inhibit prostate cancer cell invasion and migration by targeting YES proto-oncogene 1

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Prostate cancer (PCa) is an aggressive malignancy impacting the male genitourinary system.
• Understanding the molecular mechanisms underlying PCa progression is crucial for developing effective therapies.

Purpose of the Study:

• To investigate the role and effects of microRNA-140 (miR-140) in prostate cancer.
• To determine if miR-140 can be a potential therapeutic target for PCa.

Main Methods:

• PCa cells were transfected with miR-140 mimics or a negative control.
• Cell proliferation, migration, and invasion were assessed using MTT, wound healing, and Transwell assays.
• The interaction between miR-140 and YES proto-oncogene 1 (YES1) was validated using a Luciferase reporter assay.

Main Results:

• miR-140 was found to be downregulated in PCa cells and tissues.
• Overexpression of miR-140 significantly inhibited PCa cell proliferation, migration, and invasion.
• YES1 was identified as a direct target of miR-140, with inverse correlation between their expression levels.

Conclusions:

• miR-140 exerts significant tumor-suppressive effects in prostate cancer by inhibiting YES1.
• Both miR-140 and YES1 represent potential therapeutic targets for prostate cancer treatment.